255 related articles for article (PubMed ID: 27003468)
1. A Quality by design (QbD) approach on starch-based nanocapsules: A promising platform for topical drug delivery.
Marto J; Gouveia LF; Gonçalves LM; Gaspar DP; Pinto P; Carvalho FA; Oliveira E; Ribeiro HM; Almeida AJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():177-185. PubMed ID: 27003468
[TBL] [Abstract][Full Text] [Related]
2. Design of minocycline-containing starch nanocapsules for topical delivery.
Marto JM; Gouveia LF; Gonçalves LMD; Ribeiro HM; Almeida AJ
J Microencapsul; 2018 Jun; 35(4):344-356. PubMed ID: 29889598
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical properties of lipid nanoparticles: effect of lipid and surfactant composition.
Martins S; Tho I; Ferreira DC; Souto EB; Brandl M
Drug Dev Ind Pharm; 2011 Jul; 37(7):815-24. PubMed ID: 21214488
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticles.
El-Naggar ME; El-Rafie MH; El-sheikh MA; El-Feky GS; Hebeish A
Int J Biol Macromol; 2015 Nov; 81():718-29. PubMed ID: 26358550
[TBL] [Abstract][Full Text] [Related]
5. Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance.
Marto J; Ruivo E; Lucas SD; Gonçalves LM; Simões S; Gouveia LF; Felix R; Moreira R; Ribeiro HM; Almeida AJ
Eur J Pharm Biopharm; 2018 Jun; 127():1-11. PubMed ID: 29409864
[TBL] [Abstract][Full Text] [Related]
6. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
7. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design,
Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY
Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769
[TBL] [Abstract][Full Text] [Related]
8. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
9. Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles.
Rivera-Rodríguez GR; Alonso MJ; Torres D
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):481-7. PubMed ID: 23954509
[TBL] [Abstract][Full Text] [Related]
10. Sonication-assisted drug encapsulation in layer-by-layer self-assembled gelatin-poly (styrenesulfonate) polyelectrolyte nanocapsules: process optimization.
Pandey AP; Singh SS; Patil GB; Patil PO; Bhavsar CJ; Deshmukh PK
Artif Cells Nanomed Biotechnol; 2015; 43(6):413-24. PubMed ID: 24684490
[TBL] [Abstract][Full Text] [Related]
11. Nanoencapsulation of lemon essential oil in Chitosan-Hicap system. Part 1: Study on its physical and structural characteristics.
Hasani S; Ojagh SM; Ghorbani M
Int J Biol Macromol; 2018 Aug; 115():143-151. PubMed ID: 29653169
[TBL] [Abstract][Full Text] [Related]
12. Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Maupas C; Moulari B; Béduneau A; Lamprecht A; Pellequer Y
Int J Pharm; 2011 Jun; 411(1-2):136-41. PubMed ID: 21463666
[TBL] [Abstract][Full Text] [Related]
13. Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study.
Badria F; Mazyed E
Drug Des Devel Ther; 2020; 14():3697-3721. PubMed ID: 32982176
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipid nanoparticle formulations on skin delivery of a lipophilic substance.
Vidlářová L; Hanuš J; Veselý M; Ulbrich P; Štěpánek F; Zbytovská J
Eur J Pharm Biopharm; 2016 Nov; 108():289-296. PubMed ID: 27449632
[TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into pH-responsive drug release of self-assembling human serum albumin-silk fibroin nanocapsules.
Tallian C; Herrero-Rollett A; Stadler K; Vielnascher R; Wieland K; Weihs AM; Pellis A; Teuschl AH; Lendl B; Amenitsch H; Guebitz GM
Eur J Pharm Biopharm; 2018 Dec; 133():176-187. PubMed ID: 30291964
[TBL] [Abstract][Full Text] [Related]
17. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
Salunkhe SS; Bhatia NM; Bhatia MS
Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
[TBL] [Abstract][Full Text] [Related]
18. Starch-based Pickering emulsions for topical drug delivery: A QbD approach.
Marto J; Gouveia L; Jorge IM; Duarte A; Gonçalves LM; Silva SMC; Antunes F; Pais AACC; Oliveira E; Almeida AJ; Ribeiro HM
Colloids Surf B Biointerfaces; 2015 Nov; 135():183-192. PubMed ID: 26263210
[TBL] [Abstract][Full Text] [Related]
19. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
[TBL] [Abstract][Full Text] [Related]
20. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
